These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10542204)

  • 1. Function of the factor I modules (FIMS) of human complement component C6.
    DiScipio RG; Linton SM; Rushmere NK
    J Biol Chem; 1999 Nov; 274(45):31811-8. PubMed ID: 10542204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5.
    Thai CT; Ogata RT
    J Immunol; 2004 Oct; 173(7):4547-52. PubMed ID: 15383587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT; Ogata RT
    J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of the C6A form cDNA of the mouse sixth complement component: functional integrity despite the absence of factor I modules.
    Yu JX; Bradt BM; Cooper NR
    Immunogenetics; 2000 Aug; 51(10):779-87. PubMed ID: 10970092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.
    Mondragón-Palomino M; Piñero D; Nicholson-Weller A; Laclette JP
    J Mol Evol; 1999 Aug; 49(2):282-9. PubMed ID: 10441679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
    Groggel GC; Adler S; Rennke HG; Couser WG; Salant DJ
    J Clin Invest; 1983 Dec; 72(6):1948-57. PubMed ID: 6227634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM; Hammer CH; Vanguri P; Shin ML
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5118-21. PubMed ID: 6946459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization.
    Yamamoto K; Migita S
    J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.